SERA PROGNOSTICS, INC. Payments to Acquire Debt Securities, Available-for-sale
SERA PROGNOSTICS, INC. (SERA) reported Payments to Acquire Debt Securities, Available-for-sale of $11.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-12
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $10.66M, a 30.29% decline year-over-year.
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $1.01M, a 98.22% decline year-over-year.
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $7.78M, a 41.58% increase year-over-year.
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $7.97M, a 110.82% increase year-over-year.
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $87.61M, a 144.51% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $35.83M, a 33.82% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $54.14M, a 12.63% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $48.07M, a 41.41% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $11.67M 10-Q · filed 2026-08-12 | $19.45M derived: sum of 3 quarters · filed 2026-08-12 | $27.42M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.01M 10-Q · filed 2026-05-06 | $8.79M derived: sum of 2 quarters · filed 2026-05-06 | $16.76M derived: sum of 3 quarters · filed 2026-05-06 | $32.05M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $7.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $15.75M derived: sum of 2 quarters · filed 2026-03-18 | $31.05M derived: sum of 3 quarters · filed 2026-08-12 | $87.61M 10-K · filed 2026-03-18 |
| 2025-09-30 | $7.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $23.27M derived: sum of 2 quarters · filed 2026-08-12 | $79.83M 10-Q · filed 2025-11-13 | $85.33M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $15.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $71.86M 10-Q · filed 2026-08-12 | $77.36M derived: sum of 3 quarters · filed 2026-08-12 | $81.14M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $56.56M 10-Q · filed 2026-05-06 | $62.06M derived: sum of 2 quarters · filed 2026-05-06 | $65.84M derived: sum of 3 quarters · filed 2026-05-06 | $76.17M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $9.28M derived: sum of 2 quarters · filed 2026-03-18 | $19.60M derived: sum of 3 quarters · filed 2026-03-18 | $35.83M 10-K · filed 2026-03-18 |
| 2024-09-30 | $3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $14.11M derived: sum of 2 quarters · filed 2025-11-13 | $30.34M 10-Q · filed 2025-11-13 | $35.23M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $10.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $26.56M 10-Q · filed 2025-08-06 | $31.45M derived: sum of 3 quarters · filed 2025-08-06 | $57.63M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $16.23M 10-Q · filed 2025-05-07 | $21.12M derived: sum of 2 quarters · filed 2025-05-07 | $47.30M derived: sum of 3 quarters · filed 2025-05-07 | $55.63M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $31.07M derived: sum of 2 quarters · filed 2025-03-19 | $39.41M derived: sum of 3 quarters · filed 2025-03-19 | $54.14M 10-K · filed 2025-03-19 |
| 2023-09-30 | $26.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $34.51M derived: sum of 2 quarters · filed 2024-11-06 | $49.25M 10-Q · filed 2024-11-06 | $55.73M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $8.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $23.07M 10-Q · filed 2024-08-07 | $29.55M derived: sum of 3 quarters · filed 2024-08-07 | $49.92M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $14.73M 10-Q · filed 2024-05-08 | $21.22M derived: sum of 2 quarters · filed 2024-05-08 | $41.59M derived: sum of 3 quarters · filed 2024-05-08 | $56.19M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $26.86M derived: sum of 2 quarters · filed 2024-03-20 | $41.46M derived: sum of 3 quarters · filed 2024-03-20 | $48.07M 10-K · filed 2024-03-20 |
| 2022-09-30 | $20.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $34.97M derived: sum of 2 quarters · filed 2023-11-08 | $41.59M 10-Q · filed 2023-11-08 | $56.07M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $14.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $21.22M 10-Q · filed 2023-08-09 | $35.70M derived: sum of 3 quarters · filed 2023-08-09 | $103.27M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $6.61M 10-Q · filed 2023-05-10 | $21.10M derived: sum of 2 quarters · filed 2023-05-10 | $88.67M derived: sum of 3 quarters · filed 2023-05-10 | $88.67M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $14.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $82.06M derived: sum of 2 quarters · filed 2023-03-22 | $82.06M derived: sum of 3 quarters · filed 2023-03-22 | $82.06M 10-K · filed 2023-03-22 |
| 2021-09-30 | $67.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $67.57M derived: sum of 2 quarters · filed 2022-11-09 | $67.57M 10-Q · filed 2022-11-09 | $67.57M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-08-10 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |